{{Rsnum
|rsid=3764220
|Gene=SCG3
|Chromosome=15
|position=51679861
|Orientation=plus
|GMAF=0.07254
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SCG3
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 80.9 | 16.2 | 2.9
| JPT | 74.3 | 24.8 | 0.9
| YRI | 60.5 | 35.4 | 4.1
| ASW | 66.7 | 29.8 | 3.5
| CHB | 80.9 | 16.2 | 2.9
| CHD | 81.7 | 18.3 | 0.0
| GIH | 99.0 | 1.0 | 0.0
| LWK | 71.8 | 27.3 | 0.9
| MEX | 0.0 | 0.0 | 0.0
| MKK | 93.6 | 6.4 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

This SNP in the [[SCG3]] gene was significantly associated with an obesity phenotype. Two other SNPs, [[rs16964465]] and [[rs16964476]], affected the transcriptional activity of [[SCG3]] and subjects with their minor alleles seemed to be resistant (OR 9.3) to [[obesity]]. {{PMID|17200173}}

{{ neighbor
| rsid = 16964465
| distance = 289
}}

{{omim
|desc=SECRETOGRANIN III; SCG3
|id=611796
|rsnum=3764220
}}

{{PMID Auto
|PMID=21796137
|Title=Association of variations in the FTO, SCG3 and MTMR9 genes with metabolic syndrome in a Japanese population
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}